I35.0 I35.1
Conditions
Interventions
Group 1: An annual follow-up should take place over a period of five years. In this follow-up an echocardiographic examination should occur, to determine the functionality of the Trifecta biological p
Sponsors
Herzzentrum Leipzig GmbH - Universitätsklinik für Herzchirurgie
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: All patients who have received a trifecta biological prosthesis at the heart centre Leipzig during the European pivotal study (CS05002TV) and who have given informed consent for this study.
Exclusion criteria
Exclusion criteria: Patients who did not signed the informed consent form.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| functioning of Trifecta bioprosthesis by annual echocardiographic examination for 5 years | — |
Secondary
| Measure | Time frame |
|---|---|
| Analysis of the clinical symptoms, adverse events, survival rates, re operations, occurrence of endocarditis and stroke within 5 years | — |
Countries
Germany
Contacts
Public ContactSven Lehmann
Herzzentrum Leipzig GmbH - Universitätsklinik für Herzchirurgie
Outcome results
None listed